Zentalis Pharmaceuticals, Inc. (ZNTL): Shares Outstanding

Annual figures by period end, from SEC filings.

69.09M
As of 2025-12-31
71.67M
As of 2026-06-30
+5.2%
3-year compound annual growth
+11.0%
5-year compound annual growth
71.28M2020-12-31: 41.04M2021-12-31: 45.49M2022-12-31: 59.28M2023-12-31: 70.77M2024-12-31: 71.28M2025-12-31: 69.09M69.09M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3169.09M-3.1%2026-03-26, Balance as of period end
2024-12-3171.28M+0.7%2026-03-26, Balance as of period end
2023-12-3170.77M+19.4%2025-03-26, Balance as of period end
2022-12-3159.28M+30.3%2024-02-27, Balance as of period end
2021-12-3145.49M+10.8%2023-03-01, Balance as of period end
2020-12-3141.04Mn/a2022-02-24, Balance as of period end